Post-authorization Safety Study: Ponesimod Pregnancy Outcomes Program Utilizing Enhanced Pharmacovigilance Monitoring (POEM)

05/12/2022
12/12/2024
EU PAS number:
EUPAS50031
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other
Spontaneous reports of suspected adverse drug reactions

Data sources (types), other

Prospective patient-based data collection, Enhanced pharmacovigilance monitoring
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No